Fast delivery within 72 Hours
Exemestane ZPHC — 25 mg × 100 tablets
69 CFA
100 film-coated tablets × 25 mg
- Mechanism: permanently deactivates aromatase, lowering estrogen by ≈ 85 % and boosting endogenous testosterone.
- Research uses: post-cycle therapy, estrogen-dependent breast cancer models, mitigation of gynecomastia & water retention.
- Dose guide (research): 12.5 mg EOD for mild E2 control · 25 mg EOD during high-aromatase cycles · 25 mg daily × 2 weeks in PCT protocols.
- Lipid support: monitor HDL/LDL; consider omega-3 or niacin supplementation.
- QC: ≥ 99 % API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.
*For laboratory research use only. Not approved as a medicinal product.*
Shipping & Delivery
-
Courier delivery
Our courier will deliver to the specified address
2-3 Days
From $20
-
DHL Courier delivery
DHL courier will deliver to the specified address
2-3 Days
From $40
-
Warranty 1 year
-
Free 30-Day returns
Description
Exemestane ZPHC — 25mg
100 Film-Coated Tablets
Exemestane ZPHC is a steroidal aromatase inhibitor (AI) commonly referenced in:
- Estrogen-regulation research
- Endocrine-response studies
- Hormonal pathway analysis
- Post-cycle hormonal recovery models
Exemestane functions as an:
- Irreversible aromatase inhibitor
- Estrogen-suppression compound
- Steroidal AI research agent
The product is supplied as:
- 100 film-coated tablets
- 25mg per tablet
Product Specifications
| Specification | Details |
|---|---|
| Manufacturer | ZPHC |
| Active Ingredient | Exemestane |
| Classification | Steroidal Aromatase Inhibitor |
| Strength | 25mg per tablet |
| Presentation | 100 film-coated tablets |
| Form | Oral tablets |
| Quality Standard | ≥99% API purity (HPLC) |
| Manufacturing | GMP-compliant tablet press |
| Authentication | Scratch-code verification |
Compound Profile
Aromatase Inhibition Research
Exemestane is commonly associated with:
- Aromatase enzyme suppression studies
- Estrogen-regulation pathway analysis
- Hormonal balance and endocrine-response research
Estrogen-Control Studies
Research literature frequently references:
- Water-retention mitigation analysis
- Estrogen-related tissue response models
- Hormonal recovery pathway studies
Precision Tablet Delivery
The tablet format supports:
- Standardized dosing consistency
- Controlled laboratory protocols
- Predictable release characteristics
Key Features
Irreversible Steroidal AI
- Permanently binds and deactivates aromatase enzymes in research models
- Frequently referenced in estrogen-control studies
High-Purity Manufacturing
- ≥99% HPLC-verified purity
- GMP manufacturing standards
Secure Authentication System
- Tamper-evident packaging
- Scratch-code authenticity verification
- Controlled batch-traceability standards
Safety Information
Potential adverse effects associated with aromatase inhibitor exposure may include:
- Joint discomfort or dryness
- Fatigue or reduced energy levels
- Mood changes
- Reduced estrogen-related protective effects
- Lipid profile alterations
- Bone-density concerns with prolonged exposure
Improper or unsupervised hormone modulation may increase endocrine and cardiovascular risks.
Important Medical Guidance
Hormone-related compounds should only be used:
- Under supervision of a qualified healthcare professional
- With appropriate hormone and lipid monitoring
- According to local medical regulations and prescription laws
Misuse may result in serious health complications.
Storage Instructions
| Condition | Recommendation |
|---|---|
| Temperature | Store in a cool, dry place |
| Moisture | Protect from humidity |
| Light Exposure | Keep away from direct sunlight |
| Safety | Keep out of reach of children |
You may also like
5-Amino-1MQ
55 CFA – 80 CFAPrice range: 55 CFA through 80 CFA
ABP-7 Peptide
50 CFA – 80 CFAPrice range: 50 CFA through 80 CFA
Acetyl Hexapeptide-3 (Argireline)
20 CFA – 195 CFAPrice range: 20 CFA through 195 CFAAdamax Peptide
Adipotide Peptide
